GlassScriptPhysician profile
Salman S Aly
NPI 1326287715
$9,636.17
in general payments reported to CMS, 2019-2025
41 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,402 · 2020: $1,413 · 2021: $1,323 · 2022: $1,419 · 2023: $1,335 · 2024: $1,701 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,946 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,945.94 |
| Education | $133.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,710.07 | 2019-2025 | Grafix Pl, Renasys Touch, Grafix |
| Abbvie INC. | $1,004.77 | 2021-2025 | Vraylar, Dalvance, Ubrelvy |
| Mimedx Group, INC. | $591.75 | 2024-2025 | |
| Reddress USA, INC. | $371.61 | 2024 | |
| Allergan, INC. | $351.60 | 2019-2020 | |
| Boston Scientific Corporation | $290.25 | 2022-2024 | Ekosonic |
| Astrazeneca Pharmaceuticals LP | $277.19 | 2022-2023 | Farxiga |
| Revance Therapeutics, INC. | $261.66 | 2024-2025 | Daxxify |
| Senseonics, Incorporated | $157.00 | 2019-2020 | |
| Osiris Therapeutics INC. | $152.04 | 2019 | |
| Organogenesis INC. | $151.61 | 2021-2022 | |
| Pfizer INC. | $121.75 | 2019-2025 | |
| Astellas Pharma US INC | $118.91 | 2023 | Myrbetriq |
| Abbott Laboratories | $108.05 | 2023 | Proclaim |
| Hartmann USA, INC. | $105.35 | 2020-2021 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $98.24 | 2022-2024 | Dificid, Zerbaxa |
| Paratek Pharmaceuticals, INC. | $81.17 | 2022-2023 | Nuzyra |
| Lilly USA, LLC | $76.36 | 2022 | |
| Ets Wound Care LLC | $72.85 | 2024 | Mirragen Advanced Wound Matrix |
| Misonix INC | $61.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $53.93 | 2021-2022 | |
| Eisai INC. | $41.27 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $41.26 | 2021 | |
| Mylan Specialty L.P. | $34.94 | 2020 | |
| Convatec INC. | $29.19 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $28.51 | 2022 | |
| Insmed, INC. | $26.84 | 2022 | |
| Galderma Laboratories, L.P. | $23.82 | 2025 | |
| Scilex Pharmaceuticals INC. | $21.65 | 2019 | |
| Shionogi INC | $16.85 | 2020 | |
| Shield Therapeutics INC | $16.75 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $16.48 | 2019 | |
| Solventum Corporation | $16.33 | 2024 | V.A.C. Dermatac, Activ.A.C. |
| Novartis Pharmaceuticals Corporation | $14.78 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.22 | 2020 | |
| Urgo Medical North America, LLC | $14.20 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Tactile Systems Technology INC | $13.80 | 2019 | |
| Cashflow Solutions, LLC | $13.30 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Melinta Therapeutics, LLC | $12.96 | 2019 | |
| Reapplix INC. | $11.85 | 2021 | |
| Medela LLC | $9.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Aly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.